Skip to main content

Advertisement

Log in

Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To compare visual and anatomical outcomes of half-fluence (HF) and half-dose (HD) photodynamic therapy (PDT) in chronic central serous chorioretinopathy (CSC). Particular focus was given to photoreceptor recovery rate following treatment.

Methods

Retrospective review of 52 chronic CSC patients who underwent HF- or HD-PDT (26 patients per group). Best-corrected visual acuity and spectral-domain optical coherence tomography findings were compared between groups.

Results

Average follow-up for HF- and HD-PDT was 20.7 ± 7.2 and 22.3 ± 6.1 months respectively. Both groups had significant visual acuity improvements, as well as central foveal and subfoveal choroidal thickness reductions. Measured parameters were not significantly different between groups at any time point examined. Complete photoreceptor recovery, defined as a continuous ellipsoid zone with a discernible interdigitation zone, was observed at 12 months in 19 (73 %) and 14 patients (54 %) in the HF- and HD-PDT groups respectively (p = 0.150). Overall photoreceptor recovery rate was not different between groups (p = 0.301, log-rank test). Delayed (>12 months) photoreceptor recovery was significantly associated with baseline external limiting membrane disruption (OR: 21.7, 95 % CI: 1.7–285.4, p = 0.019), disease duration (years, OR: 1.9, 95 % CI: 1.2–3.0, p = 0.005), and fovea-to-PDT spot center distance (100 μm unit, OR: 0.74, 95 % CI 0.56–0.97, p = 0.027). However, delayed photoreceptor recovery was not significantly associated with PDT modality.

Conclusion

Both HF- and HD-PDT are effective in treating chronic CSC. No significant differences in visual or anatomical outcomes were observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63(Suppl):1–139

    PubMed  Google Scholar 

  2. Prunte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121:26–34

    Article  CAS  PubMed  Google Scholar 

  3. Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16:203–213

    Article  CAS  PubMed  Google Scholar 

  4. Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469–1473. doi:10.1097/IAE.0b013e3181be0a83

    Article  PubMed  Google Scholar 

  5. Schmidt-Erfurth U, Hasan T (2000) Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 45:195–214

    Article  CAS  PubMed  Google Scholar 

  6. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752–763

    Article  PubMed  Google Scholar 

  7. Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288–298

    Article  PubMed  Google Scholar 

  8. Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF (2014) Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology. doi:10.1016/j.ophtha.2013.11.040

    Google Scholar 

  9. Colucciello M (2006) Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 26:239–242

    Article  PubMed  Google Scholar 

  10. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453–1458

    Article  PubMed Central  PubMed  Google Scholar 

  11. Reibaldi M, Boscia F, Avitabile T, Uva MG, Russo A, Zagari M, Occhipinti F, Russo V, Reibaldi A, Longo A (2011) Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 151:953–960.e952. doi:10.1016/j.ajo.2010.12.007

    Article  PubMed  Google Scholar 

  12. Shin JY, Woo SJ, Yu HG, Park KH (2011) Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina 31:119–126. doi:10.1097/IAE.0b013e3181e378f2

    Article  CAS  PubMed  Google Scholar 

  13. Smretschnig E, Ansari-Shahrezaei S, Hagen S, Glittenberg C, Krebs I, Binder S (2013) Half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Retina 33:316–323. doi:10.1097/IAE.0b013e318280769c

    Article  CAS  PubMed  Google Scholar 

  14. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85–93. doi:10.1097/IAE.0b013e318156777f

    Article  PubMed  Google Scholar 

  15. Uetani R, Ito Y, Oiwa K, Ishikawa K, Terasaki H (2012) Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy. Eye (Lond) 26:640–649. doi:10.1038/eye.2012.66

    Article  CAS  Google Scholar 

  16. Nicolo M, Eandi CM, Alovisi C, Grignolo FM, Traverso CE, Musetti D, Piccolino FC (2014) Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 157(5):1033–1037. doi:10.1016/j.ajo.2014.01.022

    Article  PubMed  Google Scholar 

  17. Alkin Z, Perente I, Ozkaya A, Alp D, Agca A, Aygit ED, Korkmaz S, Yazici AT, Demirok A (2014) Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Clin Ophthalmol 8:685–690. doi:10.2147/opth.s58617

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811–815. doi:10.1016/j.ajo.2008.12.008

    Article  PubMed  Google Scholar 

  19. Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792–1799. doi:10.1016/j.ophtha.2010.01.023

    Article  PubMed  Google Scholar 

  20. Hua R, Liu L, Li C, Chen L (2014) Evaluation of the effects of photodynamic therapy on chronic central serous chorioretinopathy based on the mean choroidal thickness and the lumen area of abnormal choroidal vessels. Photodiagnosis Photodyn Ther 11(4):519–525. doi:10.1016/j.pdpdt.2014.07.005

    Article  CAS  PubMed  Google Scholar 

  21. Srinivasan VJ, Monson BK, Wojtkowski M, Bilonick RA, Gorczynska I, Chen R, Duker JS, Schuman JS, Fujimoto JG (2008) Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 49:1571–1579. doi:10.1167/iovs. 07-0838

    Article  PubMed Central  PubMed  Google Scholar 

  22. Spaide RF, Curcio CA (2011) Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 31:1609–1619. doi:10.1097/IAE.0b013e3182247535

    Article  PubMed Central  PubMed  Google Scholar 

  23. Gharbiya M, Grandinetti F, Scavella V, Cecere M, Esposito M, Segnalini A, Gabrieli CB (2012) Correlation between spectral-domain optical coherence tomography findings and visual outcome after primary rhegmatogenous retinal detachment repair. Retina 32:43–53. doi:10.1097/IAE.0b013e3182180114

    Article  PubMed  Google Scholar 

  24. Itoh Y, Inoue M, Rii T, Hiraoka T, Hirakata A (2012) Significant correlation between visual acuity and recovery of foveal cone microstructures after macular hole surgery. Am J Ophthalmol 153:111.e.111–119.e111. doi:10.1016/j.ajo.2011.05.039

  25. Watanabe K, Tsunoda K, Mizuno Y, Akiyama K, Noda T (2013) Outer retinal morphology and visual function in patients with idiopathic epiretinal membrane. JAMA Ophthalmol 131:172–177. doi:10.1001/jamaophthalmol.2013.686

    Article  PubMed  Google Scholar 

  26. Ojima Y, Tsujikawa A, Yamashiro K, Ooto S, Tamura H, Yoshimura N (2010) Restoration of outer segments of foveal photoreceptors after resolution of central serous chorioretinopathy. Jpn J Ophthalmol 54:55–60. doi:10.1007/s10384-009-0766-4

    Article  PubMed  Google Scholar 

  27. Ratanasukon M, Thongthong K, Bhurayanontachai P, Jirarattanasopa P (2013) Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy. Clin Ophthalmol 7:87–92. doi:10.2147/opth.s39584

    Article  PubMed Central  PubMed  Google Scholar 

  28. Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M (2011) Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Retina 31:1912–1920. doi:10.1097/IAE.0b013e3182252aa8

    Article  CAS  PubMed  Google Scholar 

  29. Fujita K, Shinoda K, Imamura Y, Matsumoto CS, Mizutani Y, Mizota A, Yuzawa M (2012) Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Am J Ophthalmol 154:579–585. doi:10.1016/j.ajo.2012.03.043

    Article  PubMed  Google Scholar 

  30. Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99. doi:10.1016/j.ajo.2004.08.037

    Article  PubMed  Google Scholar 

  31. Vasconcelos H, Marques I, Santos AR, Melo P, Pires I, Figueira J, de Abreu JF, Cachulo ML, Silva R (2013) Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 251:1697–1705. doi:10.1007/s00417-013-2270-2

    Article  CAS  PubMed  Google Scholar 

  32. Silva RM, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Gregorio T, Cachulo ML, Pires IA, Cunha-Vaz JG, Murta JN (2013) Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study. Retina 33:309–315. doi:10.1097/IAE.0b013e3182670fbe

    Article  CAS  PubMed  Google Scholar 

Download references

Financial support

This study was supported by a grant from the Seoul National University Bundang Hospital Research Fund (grant number: 11-2012-017).

Conflicts of interest

No conflicting relationship exists for any author.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Se Joon Woo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, YK., Ryoo, NK., Woo, S.J. et al. Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 253, 2063–2073 (2015). https://doi.org/10.1007/s00417-014-2926-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2926-6

Keywords

Navigation